Detailed information for compound 405554
Basic information
Technical information
- TDR Targets ID: 405554
- Name: 8-[6-[methyl-[8-[methyl-[6-(3-oxo-2,2-dipheny l-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)hexyl]a mino]octyl]amino]hexyl]-2,2-diphenyl-1,4-diox a-8-azaspiro[4.5]decan-3-one
- MW: 955.316 | Formula: C60H82N4O6
-
H donors: 0
H acceptors: 2
LogP: 12.14
Rotable bonds: 27
Rule of 5 violations (Lipinski): 2 - SMILES: CN(CCCCCCN1CCC2(CC1)OC(=O)C(O2)(c1ccccc1)c1ccccc1)CCCCCCCCN(CCCCCCN1CCC2(CC1)OC(=O)C(O2)(c1ccccc1)c1ccccc1)C
- InChi: 1S/C60H82N4O6/c1-61(43-25-7-9-27-45-63-47-37-57(38-48-63)67-55(65)59(69-57,51-29-15-11-16-30-51)52-31-17-12-18-32-52)41-23-5-3-4-6-24-42-62(2)44-26-8-10-28-46-64-49-39-58(40-50-64)68-56(66)60(70-58,53-33-19-13-20-34-53)54-35-21-14-22-36-54/h11-22,29-36H,3-10,23-28,37-50H2,1-2H3
- InChiKey: VWEQLDJRUYNWOE-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
- 8-[6-[8-[6-(3-keto-2,2-diphenyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)hexyl-methyl-amino]octyl-methyl-amino]hexyl]-2,2-diphenyl-1,4-dioxa-8-azaspiro[4.5]decan-3-one
- 8-[6-[methyl-[8-[methyl-[6-[3-oxo-2,2-di(phenyl)-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]hexyl]amino]octyl]amino]hexyl]-2,2-di(phenyl)-1,4-dioxa-8-azaspiro[4.5]decan-3-one
- 8-[6-[8-[6-[3-keto-2,2-di(phenyl)-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]hexyl-methyl-amino]octyl-methyl-amino]hexyl]-2,2-di(phenyl)-1,4-dioxa-8-azaspiro[4.5]decan-3-one
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Rattus norvegicus | Muscarinic acetylcholine receptor M2 | Starlite/ChEMBL | No references |
| Rattus norvegicus | Muscarinic acetylcholine receptor M1 | Starlite/ChEMBL | No references |
| Rattus norvegicus | Muscarinic acetylcholine receptor M3 | Starlite/ChEMBL | No references |
| Rattus norvegicus | Muscarinic acetylcholine receptor M4 | Starlite/ChEMBL | No references |
Predicted pathogen targets for this compound
By orthology
| Species | Potential target | Known druggable target/s | Ortholog Group |
|---|---|---|---|
| Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133264 | All targets in OG5_133264 |
| Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133264 | All targets in OG5_133264 |
By sequence similarity to non orthologous known druggable targets
Obtained from network model
Ranking Plot
Putative Targets List
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| Ki (binding) | = -7.88 | Inhibition of binding of [3H]-pirenzepine to muscarinic receptor (M1) in rat cortex homogenates | ChEMBL. | No reference |
| Ki (binding) | = -6.27 | Inhibition of binding of [3H]-N-methylscopolamine to Muscarinic acetylcholine receptor M4 in NG 108-15 cell homogenates | ChEMBL. | No reference |
| Ki (binding) | = -6.2 | Inhibition of binding of [3H]-N-methylscopolamine to muscarinic receptor (M2) in rat heart homogenates | ChEMBL. | No reference |
| Ki (binding) | = -6.01 | Inhibition of binding of [3H]-N-methylscopolamine to muscarinic receptor (M3) in rat submaxillary gland homogenates | ChEMBL. | No reference |
| Log Ki (binding) | = 6.01 | Inhibition of binding of [3H]-N-methylscopolamine to muscarinic receptor (M3) in rat submaxillary gland homogenates | ChEMBL. | No reference |
| Log Ki (binding) | = 6.2 | Inhibition of binding of [3H]-N-methylscopolamine to muscarinic receptor (M2) in rat heart homogenates | ChEMBL. | No reference |
| Log Ki (binding) | = 6.27 | Inhibition of binding of [3H]-N-methylscopolamine to Muscarinic acetylcholine receptor M4 in NG 108-15 cell homogenates | ChEMBL. | No reference |
| Log Ki (binding) | = 7.88 | Inhibition of binding of [3H]-pirenzepine to muscarinic receptor (M1) in rat cortex homogenates | ChEMBL. | No reference |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL194216
- PubChem: 10418420
Bibliographic References
No literature references available for this target.
If you have references for this compound, please enter them in a user comment (below) or Contact us.